BlackRock’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3K Hold
4,670
﹤0.01% 5235
2025
Q4
$36.8K Hold
4,670
﹤0.01% 5110
2025
Q3
$22.8K Hold
4,670
﹤0.01% 5128
2025
Q2
$27.6K Buy
4,670
+2,198
+89% +$11.6K ﹤0.01% 5096
2025
Q1
$14.4K Buy
+2,472
New +$17.1K ﹤0.01% 5131
2021
Q2
Sell
-1,181
Closed -$24K 5550
2021
Q1
$24K Hold
1,181
﹤0.01% 5009
2020
Q4
$24K Sell
1,181
-877
-43% -$16.1K ﹤0.01% 4762
2020
Q3
$36K Buy
+2,058
New +$32.7K ﹤0.01% 4647

Other funds holding PROF

BlackRock's PROF Position: Q1 2026 in Review

BlackRock held its Profound Medical (PROF) position steady in Q1 2026 at 4,670 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5235.

BlackRock first reported a position in PROF in Q3 2020 and has held it in 8 quarters since. The position peaked at $36.8K in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • BlackRock held 4,670 shares of Profound Medical worth $30.3K as of Q1 2026.
  • BlackRock left its Profound Medical share count unchanged in Q1 2026.
  • Profound Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5235 holding.
  • BlackRock first reported a position in Profound Medical in Q3 2020 and has held it in 8 quarters since.
  • BlackRock's Profound Medical position peaked at $36.8K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.